EcoDrugPlus

Ensembl ID : ENSMAUG00000009750
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSMAUG00000017696
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSMAUG00000001033
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSMAUG00000000693
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSMAUG00000004450
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSMAUG00000017437
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSMAUG00000022194
Gene Symbol: -
Cross references: -
254 Possible Orthologues:

Ensembl ID : ENSMAUG00000002879
Gene Symbol: -
Cross references: -
277 Possible Orthologues:

Ensembl ID : ENSMAUG00000000961
Gene Symbol: -
Cross references: -
298 Possible Orthologues:

Ensembl ID : ENSMAUG00000001272
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).